Bản Tuyên Bố Đồng Thuận Cập Nhật Châu Âu về Chẩn Đoán và Điều Trị ADHD ở Người Lớn

European Psychiatry - Tập 56 Số 1 - Trang 14-34 - 2019
J. J. Sandra Kooij1,2, Denise Bijlenga1, Luana Salerno3, Rafał Jaeschke4, István Bitter5, Judit Balázs6, Johannes Thome7, Geert Dom8, Siegfried Kasper9, Carlos N. Filipe10, Steven Stes11, Pavel Mohr12,13, Sami Leppämäki14, Miguel Casas15,16,17,18, Julio Bobes19, Jane McCarthy20,21, Vanesa Richarte22,23,24, Alexandra Philipsen25, Artemios Pehlivanidis26, Asko Niemelä27, B. Styr28, Bengi Semerci29, Blanca Bolea-Alamañac30, Dan Edvinsson31, Dieter Baeyens32, Dora Wynchank1, Esther Sobanski33,34, Fiona McNicholas35, Hervé Caci36, I. Mihailescu37, Iris Manor38, Iuliana Dobrescu39, Takuya Saito40, J. Krause41, John Fayyad42, Josep Antoni Ramos‐Quiroga15,16,43,17, Karin Foeken44, Florina Rad45,46, Marios Adamou47, Martin D. Ohlmeier48, Michael Fitzgerald49, Michael Gill50, Michael B. Lensing51, Nahit Motavallı Mukaddes52, Paweł Brudkiewicz53, Peik Gustafsson54, Pekka Tani55, P. Oswald56, P.J. Carpentier57, Pietro De Rossi58,59, Richard Delorme60, Silvana Simoska61, Stefano Pallanti62, Susan Young63, Susanne Bejerot64, Tuula Lehtonen65, James Kustow66,67, Ulrich Müller-Sedgwick68,69, Tatja Hirvikoski70, Valentino Antonio Pironti71, Ylva Ginsberg72, Zsolt Félegyházy73, María Paz García‐Portilla74, Philip Asherson75
1aPsyQ Psycho-Medical Programs, Expertise Center Adult ADHD, Carel Reinierszkade 197, 2593 HRThe Hague, The Netherlands
2bAmsterdam UMC, LocationVUMc, Dept. of Psychiatry, Amsterdam, the Netherlands
3INS, Institute of Neuroscience, Florence, Italy
4Jagiellonian University Medical College, Section of Affective Disorders, Department of Psychiatry, Krakow, Poland
5JSemmelweis University, Department of Psychiatry, Budapest, Hungary
6cInstitute of Psychology, Eotvos Lorand University, Vadaskert Child Psychiatric Hospial and Outpatient Clinic, Budapest, Hungary
7SThome, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitatsmedizin Rostock, Rostock, Germany
8XAntwerp University (UA, CAPRI), Boechout, Belgium
9dMedical University Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
10Nova Medical School. Universidade NOVA Lisboa, Lisboa, Portugal
11eUniversity Psychiatric Center, KU Leuven, Kortenberg, Belgium
12Third Faculty of Medicine, Charles University, Prague, Czech Republic
13WNational Institute of Mental Health, Klecany, Czech Republic
14fHelsinki University Central Hospital, Department of Psychiatry, HUS, Finland
15Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Catalonia, Spain
16Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
17Psychiatric Genetics Unit, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
18gDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain
19ODepartment of Psychiatry, School of Medicine, University of Oviedo - Centro de Investigación Biomédica and Red de Salud Mental, CIBERSAM, Oviedo, Spain
20Midland Regional Forensic Service, Hamilton, New Zealand
21hVisiting senior lecturer, King's College London, United Kingdom
22Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona
23Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
24iDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona
25jDPC Naestved, Ladby, Naestved, Region SjaellandDenmark
26National and Kapodistrian University of Athens Medical School, Eginition Hospital, Department of Psychiatry, Athens, Greece
27kWellmind Terveys Oy, Oulu, Finland
28lMccabi Health Services (H.M.O), Tel Aviv, Israel
29Hasan Kalyoncu University, Poyracık Sokak, Istanbul, Turkey
30mGeneral Systems Division, Centre for Addiction and Mental Health/ Dept. Of Psychiatry, University of Toronto, Toronto, Canada
31nUppsala University, Uppsala University Hospital, Akademiska sjukhuset, Uppsala, Stockholm, Sweden
32oParenting and Special Education, KU Leuven, Leuven, Belgium
33LCentral Institute of Mental Health, Mannheim
34University Medical Center Mainz, Mainz, Germany
35University College Dublin, Dublin, Republic of Ireland
36MHopitaux Pediatriques de Nice CHU Lenval, Nice, France
37qAlexandru Obregia Clinical Hospital of Psychiatry, Bucharest, Romania
38Geha MHC, Petach-TikvaIsrael
39rUniversity of Medicine and Pharmacy "Carol Davila". Child and adolescent Psychiatry Department, Prof. Dr. Alex Obregia"Psychiatry Hospital, Bucharest, Romania
40HDepartment of Child and adolescent Psychiatry, Graduate School of Medicine, Hokkaido University, North 15,West 7, Kita-ku, Sapporo, 060-8638, Japan
41Outpatient Clinic, Ottobrunn, Germany
42sSt George Hospital University Medical Center, Balamand University Faculty of Medicine, Institute for Development, Research, Advocacy and Applied Care, Department of Psychiatry and Clinical Psychology, St George Hospital, Achrafieh, Beirut, Lebanon
43NDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain
44tVieux Chemin de Cagnes à La Gaude, la Gaude, France
45Child and adolescent Psychiatry Department, Prof. Dr. Alex Obregia"Psychiatry Hospital, Bucharest, Romania
46uUniversity of Medicine and Pharmacy "Carol Davila"
47vUniversity of Huddersfield and South West Yorkshire Partnership NHS, Manygates Clinic, Wakefield, England
48Klinikum Kassel, Department of Psychiatry and Psychotherapy, Kassel, Germany
49wTrinity College, Blanchardstown Village, Dublin, Republic of Ireland
50QDepartment of Psychiatry, Trinity College Dublin, School of Medicine, Dublin, Republic of Ireland
51UOslo University Hospital, Department of Rare Disorders, NevSom - Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias, Oslo, Norway
52xIstanbul Institute of Child and Adolescent Psychiatry, Istanbul, Turkey
53yCentrum Dobrej Terapii, Cracow, Poland
54Lund University, Clinical Sciences Lund, Child and Adolescent Psychiatry, Lund, Sweden
55zDepartment of Psychiatry, Clinic for Neuropsychiatry, Helsinki University Central Hospital, HUS, Finland
56High Security Hospital, CRP Les Marronniers, Tournai, Belgium
57AReinier van Arkel Mental Health Institute, 's-Hertogenbosch, Netherlands
58Department NSMOS, Faculty of Medicine and Psychology, University "Sapienza"of Rome, Rome, Italy
59YDepartment of Neurology and Psychiatry, Sapienza University of Rome, Rome
60BChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France
61CMacedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia
62DStanford University Medical Center, University of Florence, INS Institute of Neuroscience, Florence, Italy
63EPsychology Services Limited, Croydon, England
64VÖrebro Univerity, School of Medical Sciences, Campus USÖ, Örebro, Sweden
65FNeuropsykologkonsult Taina Lehtonen, Hjärup, Sweden
66Barnet Adult ADHD Service, Springwell Centre, Barnet Hospital, Barnet, England
67GBarnet Adult ADHD Service, Barnet, Enfield and Haringey NHS Mental Health Trust, London
68Adult ADHD Service, Springwell Centre / Barnet Hospital, Barnet, London, England
69KAdult ADHD Service, Barnet, Enfield & Haringey NHS Mental Health Trust, North London & Department of Psychiatry, University of Cambridge
70ZCenter for Neurodevelopmental Disorders at Karolinska Institutet (KIND), CAP Research Center, Stockholm, Sweden
71Cambridge Adult ADHD & ASD Clinic, Cambridge, England
72TStockholm Center for Eating Disorder R&D Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
73IADHD Központ(center) Budapest, Budapest, Hungary
74RDept. of Psychiatry, University of Oviedo, School of Medicine, Psychiatry, Oviedo, Spain
75PSGDP Building, Institute of Psychiatry Psychology and Neuroscience, Kings' College London, London, England

Tóm tắt

Tóm tắt

Nền tảng Rối loạn tăng động giảm chú ý (ADHD) là một trong những rối loạn tâm thần phổ biến nhất ở trẻ em, thường kéo dài đến tuổi trưởng thành và tuổi già. Tuy nhiên, ADHD hiện đang bị thiếu chẩn đoán và điều trị ở nhiều nước châu Âu, dẫn đến tình trạng triệu chứng mãn tính và suy giảm do thiếu hoặc điều trị không hiệu quả, cũng như chi phí điều trị cao.

Phương pháp Mạng lưới ADHD ở người lớn Châu Âu và Phân đoạn Rối loạn Phát triển Thần kinh xuyên suốt Cuộc sống (NDAL) của Hiệp hội Tâm thần học Châu Âu (EPA), nhằm nâng cao nhận thức và kiến thức về ADHD ở người lớn trong và ngoài châu Âu. Bản Tuyên Bố Đồng Thuận Cập Nhật Châu Âu này hướng đến việc hỗ trợ các bác sĩ lâm sàng bằng những chứng cứ nghiên cứu và kinh nghiệm lâm sàng từ 63 chuyên gia của các nước châu Âu cũng như các quốc gia khác, nơi ADHD ở người lớn được công nhận và điều trị.

Từ khóa

#Rối loạn tăng động giảm chú ý (ADHD) #chẩn đoán #điều trị #người lớn #đồng thuận châu Âu.

Tài liệu tham khảo

10.1186/1471-244X-11-116

10.1007/s12402-012-0094-2

10.1111/acps.12479

Bazire, 2010, Psychotropic drug directory 2010

10.1097/01.chi.0000246055.76167.0d

10.1007/s00406-016-0735-0

10.1081/CBI-200062410

[305] Bupropion [Internet]. U.S. National Library of Medicine. Date accessed: 22.10.2017. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+321.

10.1111/jcpp.12164

10.1016/j.biopsych.2011.03.022

10.1176/appi.ajp.2011.11010125

10.1111/bcp.12045

10.1016/j.brat.2011.01.001

10.1002/pds.3600

10.1007/s12402-010-0023-1

10.1002/14651858.CD006997.pub2

10.1185/030079904X20303

10.2147/CLEP.S72906

10.1586/14737175.2013.836301

10.1093/ejechocard/jep023

10.4324/9780203067536

10.1016/j.jaac.2016.05.025

10.1542/peds.2015-1708

Hamedi, 2014, Bupropion in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind study, Acta Med Iran, 52, 675

10.1038/sj.mp.4002100

10.1542/peds.2010-1260

10.1097/chi.0b013e31815d9af7

10.1007/s00406-007-0712-8

10.1016/j.biopsych.2010.09.053

10.1016/j.jaac.2010.11.005

10.1001/jamapsychiatry.2013.4174

10.1001/jama.2011.1830

10.1016/j.biopsych.2004.11.019

10.1016/j.jadohealth.2003.12.003

10.1001/jamapsychiatry.2015.2146

10.1136/bmj.i2550

10.1056/NEJMcp1212625

10.1016/j.neubiorev.2016.08.032

10.1007/978-1-4471-4138-9

10.1177/0269881106073219

10.1016/S2215-0366(18)30269-4

10.1177/1087054713511986

10.3109/15622975.2010.518624

10.1016/S0149-2918(00)89086-4

10.1586/ern.10.142

10.1007/s40266-015-0327-0

10.1016/S0193-953X(03)00090-X

10.1186/1744-9081-6-34

10.4088/JCP.v69n0903

10.3111/13696998.2013.800524

10.1016/j.euroneuro.2015.08.010

10.4088/JCP.08m04902pur

10.1146/annurev-med-050911-161945

10.1073/pnas.1705229114

D’Amelio, 2009, Psychoedukation und Coaching ADHS im Erwachsenenalter Manual zur Leitung von Patienten- und Angehörigengruppen

10.1016/j.jaac.2016.05.027

10.1111/j.1365-2214.2004.00440.x

10.1007/s40261-015-0336-0

10.1016/j.eurpsy.2017.07.010

10.1155/2015/982072

Argumedo, 2012, Experimental models of developmental hypothyroidism, Horm Metab Res, 44, 79, 10.1055/s-0031-1297941

[302] Guanfacine [Internet]. U.S. National Library of Medicine. Date accessed: 22.10.2017. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+631.

10.1176/appi.ajp.159.1.36

10.1177/0269881116636105

Philipsen, 2012, Psychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research, Expert rev., 12, 1217

10.1016/j.psychres.2015.12.017

10.1080/14737175.2016.1204914

10.1016/j.mehy.2012.01.034

10.1016/j.neubiorev.2018.07.010

10.1521/pedi.2010.24.6.812

Tatlow-Golden, 2017, Transitioning from child and adolescent mental health services with attention-deficit hyperactivity disorder in Ireland: case note review, Early Interv Psychiatry

10.1177/1087054716669589

10.1176/appi.ajp.2013.13050680

10.1192/bjp.bp.111.101196

10.1176/appi.ajp.2017.17030298

10.1016/j.euroneuro.2012.06.011

10.1111/jcpp.12337

10.1016/S0002-7138(09)60450-7

10.1007/s12402-016-0208-3

10.1111/jcpp.12193

10.1093/ije/dyu204

10.1016/S0140-6736(14)61684-6

Casey, 2010, Neurobiology of the adolescent brain and behavior: implications for substance use disorders, J Am Acad Child Adolesc Psychiatry, 49, 1189

10.1001/jamapsychiatry.2017.0659

10.1080/87565641.2010.549877

10.1177/0269881114542453

10.1037/0021-843X.111.2.279

10.1186/1471-244X-13-74

10.1111/j.1600-0447.1992.tb10575.x

10.1186/s12888-016-1013-4

10.1007/s12402-016-0188-3

10.1177/1087054713479663

10.1136/adc.88.10.904

Barkley, 2010, ADHD in adults: what the science says

10.1176/appi.ajp.2015.15020266

10.1089/jwh.2011.2825

10.1136/oem.2007.038448

10.2147/NDT.S62714

Yeo, 2011, The organization of the human cerebral cortex estimated by intrinsic functional connectivity, J Neurophysiol, 106, 1125, 10.1152/jn.00338.2011

10.1080/87565641.2010.549877

10.1007/s40263-014-0166-2

10.1176/appi.ajp.2012.11101521

10.1007/s11920-017-0858-7

10.1111/add.12369

10.1007/s10548-012-0258-6

10.1007/s10802-015-0093-9

10.1586/14737175.5.4.525

10.3109/08039488.2014.972975

[301] Atomoxetine [Internet]. U.S. National Library of Medicine. Date accessed: 22.10.2017. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+826.

10.1080/87565649309540541

10.1016/j.eurpsy.2014.06.003

10.1001/jamapsychiatry.2017.0298

10.1016/S1056-4993(18)30059-2

10.1176/appi.ajp.2011.11060822

Viktorin, 2016, The risk of treatment-emergent mania with methylphenidate in bipolar disorder, Am J Psychiatry

10.1016/j.clinph.2013.11.031

10.1177/1087054712441970

10.1002/(SICI)1098-2272(200001)18:1<1::AID-GEPI1>3.0.CO;2-X

10.1001/archgenpsychiatry.2011.117

Gilger, 1992, A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia, JAmAcadChild AdolescPsychiatry., 31, 343

Sherman, 1997, Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity, JAmAcadChild AdolescPsychiatry., 36, 745

10.1177/1060028013510699

[251] Asherson P, Young S, Adamou M, Bolea B, Coghill D, Gudjonsson G, et al. Handbook for Attention Deficit Hyperactivity Disorder in Adults. UKAAN, Springer Healthcare Communications; 2013.

10.1089/cap.2013.0059

10.1111/j.1601-183X.2010.00567.x

10.1016/j.euroneuro.2013.11.003

Michielsen, 2015, The burden of ADHD in older adults: a qualitative study, J Atten Disord

10.1016/j.jaac.2010.06.008

10.1016/j.paid.2008.10.003

10.1016/j.euroneuro.2013.11.011

10.1016/j.biopsych.2007.11.004

Mowlem, 2016, Validation of the mind excessively wandering scale and the relationship of mind wandering to impairment in adult ADHD, J Atten Disord

10.1016/S0140-6736(10)61109-9

10.1007/s40263-012-0019-9

Demontis, 2018, Discovery of the first genome-wide significant risk loci for ADHD, Nat Genet

10.1017/S0033291712002978

10.1371/journal.pone.0098590

10.1177/0269881114544777

10.4088/JCP.9066tx1c

10.1177/1087054711435360

10.1007/s12402-012-0085-3

10.1002/ajmg.b.31008

10.1016/j.neubiorev.2012.08.003

10.1177/0269881111412095

Klassen, 2012, Comorbid attention Deficit/Hyperactivity disorder and substance use disorder: treatment considerations, Curr Drug Abuse Rev

10.1002/9781119943440

10.1080/21622965.2012.702025

10.1001/jamapsychiatry.2017.3644

10.1038/nrdp.2015.20

10.1192/bjp.bp.109.075135

Barkley, 2011, Barkley adult ADHD rating Scale-IV (BAARS-IV)

10.1176/appi.ajp.2015.14101266

Bangs, 2007, Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression, J Child Adolesc Psychopharmacol, 17, 407, 10.1089/cap.2007.0066

10.1371/journal.pone.0063023

10.1007/s11920-012-0303-x

10.1016/j.eurpsy.2017.04.005

10.1002/ajmg.b.32335

10.2165/11539440-000000000-00000

10.1177/1087054710392538

10.1001/jama.2010.1192

10.1371/journal.pone.0116407

10.1002/hbm.22755

NICE, 2008, Attention deficit hyperactivity disorder: diagnosis and management: national Insitute for Health and Care Excellence

10.1007/s12402-014-0150-1

10.1016/j.euroneuro.2012.07.016

10.1016/j.pnpbp.2015.04.008

10.1177/1087054715625301

Hegvik, 2017, Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study, Eur Child Adolesc Psychiatry, 5, 017

10.1002/ajmg.b.30251

10.1016/j.drugalcdep.2014.08.008

10.1177/1087054708329960

10.4088/JCP.15m10083

10.1016/j.psc.2003.12.005

10.1371/journal.pone.0010621

10.1016/S2215-0366(16)30032-3

10.1186/1478-7547-3-5

10.1016/j.pscychresns.2010.01.012

[304] Lisdexamfetamine [Internet]. U.S. National Library of Medicine. Date accessed: 22.10.2017. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+834.

Almeida Montes, 2010, Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder, J Psychiatry Neurosci, 35, 238, 10.1503/jpn.090099

10.1159/000487767

Ginsberg, 2016, Läkemedel vid adhd – behandlingsrekommendation, Information från Läkemedelsverket, 13

10.1196/annals.1441.016

10.1177/1087054711428965

10.2147/NDT.S59271

10.4088/JCP.12m08144

10.1111/cch.12380

10.1016/j.jad.2012.10.011

Wender, 2001, Adults with ADD: an overview, Ann N Y Acad Sci, 931, 10.1111/j.1749-6632.2001.tb05770.x

10.1002/bsl.2005

10.1002/mpr.319

10.1111/j.1460-9568.2010.07110.x

10.1001/jamapsychiatry.2013.277

10.1017/S003329170400337X

10.1177/0269881117699361

10.1007/s12402-014-0126-1

10.1111/jgs.12261

10.1007/s12402-012-0100-8

Coghill, 2015, Services for adults with ADHD: work in progress: commentary on, Specialist adult ADHD clinics in East Anglia. BJPsych Bull., 39, 140

10.1016/j.biopsych.2009.12.032

10.1016/j.rpsm.2012.05.004

10.1001/jamapsychiatry.2016.0400

10.1007/s00406-011-0251-1

10.1002/14651858.CD005041.pub2

10.1186/1471-2261-12-41

10.1016/j.psc.2010.04.001

10.1089/10445460050167304

Chandra, 2016, Assessing the validity of the age at onset criterion for diagnosing ADHD in DSM-5, J Atten Disord, 27, 1087054716629717

10.1016/S2215-0366(17)30200-6

10.1016/j.psc.2010.01.006

10.1542/peds.2016-2509

10.1097/00004583-200011000-00018

10.4088/JCP.13m08708

10.1111/eip.12073

10.1176/appi.ajp.2011.11020281

Rubia, 2014, Brain abnormalities in attention-deficit hyperactivity disorder: a review, Rev Neurol (Paris), 58

10.1177/0269881114550353

Pettersson, 2015, Diagnosing ADHD in adults: an examination of the discriminative validity of neuropsychological tests and diagnostic assessment instruments, J Atten Disord

10.1007/s12402-016-0208-3

10.1016/j.yebeh.2013.08.001

10.1097/00004583-199706000-00009

10.1007/s10802-007-9185-5

10.1016/j.tics.2011.11.007

10.1177/1087054709351671

10.1177/1087054713506041

10.1038/mp.2011.138

10.1177/1087054711427299

10.1002/da.20549

10.1007/s00439-009-0694-x

10.1111/bcpt.12034

10.1037/h0080415

10.1111/j.1527-3458.2007.00026.x

10.1177/1087054708320414

Sharman, 2014, Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells, Neuropsychiatr Dis Treat, 10, 2275

10.1111/j.1651-2227.2007.00430.x

10.1111/jcpp.12524

10.1016/j.pscychresns.2010.08.011

10.1111/j.1469-7610.1997.tb01612.x

10.1177/1087054712441969

10.1371/journal.pone.0141342

10.1371/journal.pone.0048286

10.1016/j.biopsych.2013.09.025

10.1016/j.neuroimage.2006.10.014

10.1097/NMD.0000000000000191

10.4088/JCP.v67n0412

10.1007/s00406-007-0722-6

10.1017/S0033291704003459

10.1111/bjc.12119

King, 2006, A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents, Health Technol Assess (Rockv), 10

10.1038/mp.2010.29

Johansson, 2010, Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations, Am J Med Genet B Neuropsychiatr Genet, 153B, 1008, 10.1002/ajmg.b.31067

10.1111/j.1600-0447.2011.01786.x

10.1097/01.CHI.0000046908.27264.00

10.1016/j.comppsych.2011.02.007

10.1186/1744-9081-2-27

10.1192/bjp.bp.106.026484

10.1136/bmj.g3769

10.1177/108705470300700203

10.1001/jamapsychiatry.2013.287

10.1002/brb3.330

NICE, 2018, Diagnosis and management of ADHD in children, young people and adults

10.1177/00222194030360040801

10.1556/2006.6.2017.073

10.1007/s40264-014-0168-5

[303] Clonidine [Internet]. U.S. National Library of Medicine. Date accessed: 22.10.2017. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+73.

10.1097/YPG.0b013e328353957e

10.3109/15622975.2011.600319

10.1016/j.biopsych.2013.02.025

10.1176/appi.ajp.2010.10070948

Retz, 2010, Attention-deficit hyperactivity disorder (ADHD) in adults Key issues in mental health

10.1001/archpsyc.1976.01770120057005

10.1177/1087054713480036

10.1176/appi.ajp.2009.09060796

10.1007/s11920-008-0065-7

10.1037/14379-000

10.1016/j.ijpsycho.2004.07.005

Cunill, 2013, Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression, Pharmacoepidemiol Drug Saf, 22, 961, 10.1002/pds.3473

10.1016/j.brainres.2012.01.034

10.1016/j.brat.2004.07.001

10.1017/S003329170500471X

10.1002/ajmg.b.30861

10.1111/bcp.12138

10.1038/npp.2014.241

[113] APA. Diagnostic and Statistical Manual of Mental Disorders - DSM 5 - 5th ed. Force. APAD-T, editor. Washington, DC: American Psychiatric Publishing; 2013.

10.1017/S0033291708003917

10.1016/j.pscychresns.2011.08.005

10.1016/j.jaac.2014.05.001

Larsson, 2013, The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan, Psychol Med (Paris), 1

10.1177/1087054711416910

10.1016/j.cpr.2010.06.004

10.1097/YCO.0b013e32832c9221

10.1177/1087054712443153

10.1093/acprof:oso/9780198745556.001.0001

10.1016/j.vascn.2013.12.004

10.1017/S0033291715000756

10.1037/prj0000121

10.1177/1087054712475211

10.1007/s10198-012-0440-5

10.1186/2193-1801-3-26

Hepark, 2015, The efficacy of adapted MBCT on core symptoms and executive functioning in adults with ADHD: a preliminary randomized controlled trial, J Atten Disord, 20, 1087054715613587

10.1002/pds.564

10.2165/11633900-000000000-00000

10.1016/j.jpsychires.2010.04.026

10.1176/appi.ajp.2017.16060686

10.1186/s12875-016-0516-x

10.1016/j.biopsych.2004.11.024

Buitelaar, 2015, ADHD in childhood and/or adulthood as a risk factor for domestic violence or intimate partner violence: a systematic review, J Atten Disord, 20

10.1111/jcpp.12381

10.1038/ng.1013

10.1586/ern.09.2

10.1097/JCP.0000000000000501

10.1177/0269881108092338

10.1080/j.1440-1614.2004.01422.x

10.1016/j.eurpsy.2015.09.012

10.1017/S0033291712001067

10.1002/jclp.22317

Faraone, 2003, The worldwide prevalence of ADHD: is it an American condition?, World Psychiatry, 2, 104

Faraone, 2018, Genetics of attention deficit hyperactivity disorder, Mol Psychiatry

10.1111/jcpp.12001

10.1002/hup.1158

10.1007/s12402-014-0141-2

10.1007/s007870170036

Mannuzza, 1991, Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study, J Am Acad Child Adolesc Psychiatry, 30, 743

10.1111/jcpp.12911

10.3758/s13423-014-0793-0

10.1177/1087054712460087

Baeyens, 2017, [A comparative study of the structural stigmatisation of ADHD and autism spectrum disorder in Flemish newspapers], Tijdschr Psychiatr, 59, 269

Lichtenstein, 2013, Medication for attention deficit-hyperactivity disorder and criminality, N Engl J Med, 368, 776

10.1186/1471-244X-10-67

10.4088/JCP.12r08287

CADDRA, 2011, Canadian ADHD practice guidelines

10.1001/jamapsychiatry.2015.41

10.1002/14651858.CD007813.pub2

10.1177/0269881113519509

10.1186/1471-244X-10-112

Ptacek, 2010, Attention deficit hyperactivity disorder and eating disorders, Prague Med Rep, 111, 175

10.1093/hmg/ddl152

10.1586/14737167.4.6.625

10.1017/S0033291714000762

10.1038/mp.2009.57

Zupancic, 1998, Review of therapies for attention-deficit/hyperactivity disorde

10.1186/1471-244X-13-237

10.1097/chi.0b013e3180686d7e

10.1016/j.jad.2012.10.011

Quinn, 2014, A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis, Prim Care Companion CNS Disord, 16

10.1016/j.psc.2004.01.002

10.1177/1087054707299367

10.1016/0006-3223(95)00653-2

10.1016/j.biopsych.2016.02.018

10.2147/DDDT.S68393

Guendelman, 2015, Childhood attention-deficit/hyperactivity disorder predicts intimate partner victimization in young women, J Abnorm Child Psychol

10.1016/j.jsr.2006.09.004

10.1186/1471-244X-12-11

10.1111/j.1469-7610.2004.00247.x

Thông tin
Thông tin xuất bản

European Psychiatry

Tập 56 Số 1

14-34

Thông tin tác giả